Revance Therapeutics shares owned by Point72 Asset Management
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Point72 Asset Management
from 13F filings
Historical chart of Point72 Asset Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Point72 Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $27k | 3.1k | 8.79 |
| 2023-09-30 | $16M | 1.4M | 11.47 |
| 2023-06-30 | $18M | 691k | 25.31 |
| 2023-03-31 | $464k | 14k | 32.21 |
| 2022-06-30 | $8.4M | 606k | 13.82 |
| 2022-03-31 | $15M | 787k | 19.50 |
| 2021-12-31 | $14M | 882k | 16.32 |
| 2021-09-30 | $21M | 755k | 27.86 |
| 2021-03-31 | $7.5M | 268k | 27.95 |
| 2019-12-31 | $4.3M | 265k | 16.23 |
| 2019-09-30 | $2.8M | 218k | 13.00 |
| 2019-06-30 | $1.5M | 116k | 12.97 |